The 48-year-old shared intimate details of her dating life, she said: 'He’s not just good-looking, he’s a beautiful soul. He’s free-spirited and has really great energy.' Anita has a huge passion for ...
Countryfile star Anita Rani says she doesn’t want to “jinx” her new relationship as she admits she would consider tying the knot with her new boyfriend. Anita, 48, split from ex-husband Bhupi Rehal in ...
From ghost-story minimalism to wartime memory, Rani’s two new works, premiered here, shimmer with imagination, although issues of balance diminished the piano concerto In a crowded post-minimalist ...
A viral video from the wedding of international javelin thrower Annu Rani has stirred controversy after she and her husband allegedly fired shots into the air during the ceremony. The incident took ...
Rani Therapeutics Holdings, Inc. targets a new potential oral delivery of biologic drugs via the RaniPill. This could eventually replace injections and improve patient adherence. Their pipeline has RT ...
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® ...
This is a big month for Kate Hudson’s daughter Rani Rose! The little girl turned 7 at the beginning of October, and this week, she celebrated a milestone occasion with her mom by her side. The How to ...
Kate Hudson's seven-year-old daughter Rani Rose got her ears pierced. The Running Point actress proudly filmed the milestone and later posted the video on TikTok. Hudson shares Rani with her longtime ...
Kate Hudson's daughter has some new bling! The Song Sung Blue actress, 46, shared a video on TikTok of her daughter Rani Rose, 7, getting her first piercing. In the clip, Hudson held onto her daughter ...
Oct 17 (Reuters) - Rani Therapeutics (RANI.O), opens new tab on Friday announced a licensing deal to develop and sell an oral version of Chugai Pharmaceutical's (4519.T), opens new tab experimental ...
SAN JOSE, Calif. - Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, announced today it has entered into a securities ...
Shares of Rani Therapeutics Holdings have doubled, to $1.12, in premarket trading after the company said it has entered into a collaboration and license agreement with Chugai Pharmaceutical. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback